ST-605 phase 2 study - uncontrolled open-label study in patients with cytomegalovirus corneal endotheliitis -
Phase of Trial: Phase II
Latest Information Update: 30 May 2017
At a glance
- Drugs Ganciclovir (Primary)
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
- Sponsors Ms Science
- 24 May 2017 Status changed from active, no longer recruiting to completed.
- 21 Mar 2017 Planned End Date changed from 31 Aug 2016 to 31 Mar 2017.
- 21 Mar 2017 Status changed from recruiting to active, no longer recruiting.